ADVANCED MEDICAL SOLUTIONS GROUP PLC — Remuneration Information 2015

Sep 11, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8437Y

Advanced Medical Solutions Grp PLC

11 September 2015

11 September 2015

Advanced Medical Solutions Group plc

("AMS" or the "Group")

DIRECTORS' SHAREHOLDINGS

Advanced Medical Solutions Group plc (AIM:AMS), the global medical technology company, announces that the Board, following a recommendation from the Remuneration Committee, has granted new share options to the following Directors under the Advanced Medical Solutions Long Term Incentive Plan (the 'LTIP') on 10 September 2015.   The vesting period of these options is subject to certain performance criteria over a 3 year period.

Director	Options prior to grant	Options granted	Resultant holding
Chris Meredith, Chief Executive Officer	770,123	168,316	938,439
Mary Tavener, Group Finance Director	436,142	132,013	568,155

-     Ends -

For further information, please visit www.admedsol.com or contact:

Advanced Medical Solutions Group plc	Tel: +44 (0) 1606 545508
Chris Meredith, Chief Executive Officer Mary Tavener, Group Finance Director
Consilium Strategic Communications	Tel: +44 (0) 20 3709 5700
Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Ivar Milligan
Investec Bank PLC (NOMAD & Broker)	Tel: +44 (0) 20 7597 5970
Gary Clarence / Daniel Adams / Patrick Robb

About Advanced Medical Solutions Group plc - see www.admedsol.com 

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands ActivHeal®, LiquiBand® and RESORBA® as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in 65 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Group has approximately 470 employees.  For more information please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBDGDCUXBBGUB